Clinical Trial Update: Phase 1 Study of ELX-02 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study of ELX-02 in healthy adults completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genetic Disease
• Nonsense Mutation

Drugs mentioned

• ELX-02 (ELX-02)

Snippet

Sponsor: Eloxx Pharmaceuticals, Inc. | Conditions: Genetic Disease, Nonsense Mutation | Phase 1 | Status: COMPLETED | Results posted: 2021-03-16